维普中文期刊产品整合服务
19篇 您的检索式:作者名="Siddharth M"
    题名 作者 年代 出处 被引量
1Review of different test methods for the evaluation of stability of biodiesel 显示文摘Siddharth Jain Sharma M P 2010Renewable and Sustainable Energy Reviews2010,7,14:1
2Impact at nalysis of biodiesel on engine performance : A review 显示文摘Gaurav Dwivedi J Siddharth A M P Sharm 2011Re1 ble and Sustainable Energy Reviews2011,15,46:1
3Prospects of biodiesel from Jatropha in India:a review 显示文摘SIDDHARTH J SHARMA M P 2010Renewable and Sustainable Energy Reviews2010,14,2:1
4Oxidation stability of blends of Jat- ropba biodiesel with diesel显示文摘Siddharth J Sharma M P 2011Fuel2011,90,10:1
5Impact analysis of biodiesel on engine performance-A review显示文摘GAURAV D SIDDHARTH J SHARMA M P 2011Re- newable and Sustainable Energy Reviews2011,15,9:1
6Multidisciplinary perspective of hepatocellular carcinoma: A Pacific Northwest experience显示文摘Hepatocellular carcinoma(HCC) is the most rapidly increasing type of cancer in the United States. HCC is a highly malignant cancer, accounting for at least 14000 deaths in the United States annually, and it ranks third as a cause of cancer mortality in men. One major difficulty is that most patients with HCC are diagnosed when the disease is already at an advanced stage, and the cancer cannot be surgically removed. Furthermore, because almost all patients have cirrhosis, neither chemotherapy nor major resections are well tolerated. Clearly there is need of a multidisciplinary approach for the management of HCC. For example, there is a need for better understanding of the fundamental etiologic mechanisms that are involved in hepatocarcinogenesis, which could lead to the development of successful preventive and therapeutic modalities. It is also essential to define the cellular and molecular bases for malignant transformation of hepatocytes. Such knowledge would:(1) greatly facilitate the identification of patients at risk;(2) prompt efforts to decrease risk factors; and(3) improve surveillance and early diagnosis through diagnostic imaging modalities. Possible benefits extend also to the clinical management of this disease. Because there are many factors involved in pathogenesis of HCC,this paper reviews a multidisciplinary perspective of recent advances in basic and clinical understanding of HCC that include: molecular hepatocarcinogenesis, noninvasive diagnostics modalities, diagnostic pathology, surgical modality, transplantation, local therapy and oncological/target therapeutics.Matthew M Yeh Raymond S Yeung Smith Apisarnthanarax Renuka Bhattacharya Carlos Cuevas William P Harris Tony Lim Kiat Hon Siddharth A Padia James O Park Kevin M Riggle Sayed S Daoud 2015World Journal of Hepatology2015,7,11:1
7Oxidation stability of blends of Jatropha biodiesel with diesel 显示文摘SIDDHARTH JAIN SHARMA M P 2011Fuel2011,90,1:1
8When do creditor rights work? 显示文摘M Sat-avian and Siddharth S 2007Joumal of Comparative Economics2007,35,3:1
9Stability of biodiesel and its blends:A review显示文摘Jain Siddharth Sharma M P 2009Renewable and Sustainable Energy Reviews2009,,:1
10Inventory competition under dynamic consumer choice 显示文摘Siddharth M Garret V R 2001Operations Research2001,49,5:1
11Inventory competition under dynamic consumer choice显示文摘Siddharth M Garret V R 2001Operations Research2001,49,5:1
12J Conserv Dent显示文摘Sharma R Hegde V Siddharth M 2014Endodontic-periodontal microsurgery for combined endodonticperiodontal lesions:An overview2014,17,6:1
13Review of different test methods for the evaluation of stability of biodiesel 显示文摘Siddharth Jain Sharma M P 2010Renewable and Sustainable Energy Reviews2010,7,14:1
14Stem cells-A window to periodontal regeneration显示文摘Siddharth M Varshney S Singla A 0,,02:1
15Impact of all oral anti-hepatitis C virus therapy:A metaanalysis显示文摘AIM:To investigate the efficacy,safety,and cost of treatment of direct acting antivirals(DAAs) with and without peg interferon alfa2a(P),and/or ribavirin(R) in treating hepatitis C virus(HCV) genotype 1 patients.METHODS:MEDLINE was searched for randomized controlled trials(RCT) using DAAs for HCV treatment.Phase 1 trials and studies with investigational drugs on genotype 2 or 3,and on human immunodeficiency virus patients were excluded.Data were pooled for sustained virologic response(SVR),serious adverse effects,and drug discontinuation rate on various treatment arms in trials:P + R;1st generation DAA(telaprevir or boceprevir) + P + R;2nd generation DAA(sofosbuvir or simeprevir) + P + R;2nd generation DAA + R;two 2nd generation DAA + R;and two 2nd gen DAA.Data were analyzed separately for each arm for treatment naive and non-responders(NR) to previous treatment.The cost of treatment with each regimen for achieving one SVR was also compared.RESULTS:Twenty three RCTs(n = 9354,62% male,11% cirrhosis) were analyzed.All oral(P free) regimens with combination of 2 DAA achieved SVR above 95%.The cost of treatment to achieve an SVR with DAA based regimens was lower for NR compared to P+R regimen.However,the cost per SVR remained higher for treatment naive patients.CONCLUSION:Second generation and emerging DAAs are promising agents in HCV treatment,with a very high level of safety and efficacy.An important drawback is their high cost.However,the present meta-analysis shows that the cost per SVR for non responders(but not for naive patients) was lower compared to P + R.This finding together with the superior safety profile and better compliance makes these drugs highly attractive.It is possible that further reduction in treatment duration may make them even more cost effective.Siddharth Bansal Ashwani K Singal Brendan M Mc Guire Bhupinder S Anand 2015World Journal of Hepatology2015,7,5:1
16Impact Analysis of Biodiesel on Engine Performance-A Review显示文摘Gaurav Dwivedi Siddharth Jain Sharma M P 0,,09:1
17Endodontic-periodontal microsurgery for combined endodontic-periodontal lesions:An overview显示文摘Sharma R Hegde V Siddharth M et al 2014J Conserv Dent2014,17,6:1
18Microarchitectural analysis of image quality assess- ment algorithms显示文摘Thien D Phan Siddharth K Shah Damon M Chandler 2014Journal of Electronic Imaging2014,23,1:1
19PIK3CA基因相关过度生长综合征群的诊治规范:国际专家共识显示文摘PIK3CA基因激活突变所导致的一系列发育障碍表型谱被统称为PIK3CA基因相关过度生长综合征群(PIK3CA-related overgrowth spectrum,PROS)。临床表现分型众多,各型分类见表1A。由于基因变异发生在受精卵形成后,临床表型为嵌合体,因此PIK3CA基因变异在外周血中的阳性检出率很低,通常需要非血液标本或通过组织活检来发现超低频嵌合体。PIK3CA基因激活变异的作用为促生长,变异导致的表型取决于基因变异发生的时间、组织细胞类型、变异细胞的分布以及变异的激活强度。周清 李辛 刘晖 常国营 徐敏 王剑 顾松 王秀敏(译) Sofia Douzgou Myfanwy Rawson Eulalia Baselga Moise Danielpour Laurence Faivre Alon Kashanian Kim M Keppler-Noreuil Paul Kuentz Grazia M S Mancini Marie-Cecile Maniere Victor Martinez-Glez Victoria E Parker Robert K Semple Siddharth Srivastava Pierre Vabres Marie-Claire Y De Wit John M Graham Jr Jill Clayton-Smith Ghayda M Mirzaa Leslie G Biesecker 2023临床儿科杂志2023,41,11:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费